FDC Latest Share Price (FDC)
TODAY IN ONE LINE
FDC fell 1.1% on average volume, in line with Nifty's -0.3% move.
With a market cap of ₹5,568.1 Cr., it trades at a P/E of 19.03. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
FDC flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 166.8% YoY
- ●Healthy Operating MarginsOPM is structurally strong at 18.0%
- ●High Promoter HoldingPromoters hold 69.7% skin-in-the-game
- ●Steady Dividend YieldReliable 1.46% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 1.9% YoY
- ●FII SellingFII holding decreased by 1.00% QoQ
Latest FDC News
What changed recently?
Recent events, corporate actions, and announcements.
FDC valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for FDC, framed against the sector median so the premium or discount is obvious at a glance.
FDC trades at a P/E of 19.03× and P/B of 2.24×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
FDC technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for FDC — derived from the latest tape, not yesterday's close.
FDC last traded at ₹341.45 with an intraday range of ₹339–₹344.8 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹341.45| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 356.10 | +14.65 | +4.29% |
| R3 | 350.30 | +8.85 | +2.59% |
| R2 | 347.55 | +6.10 | +1.79% |
| R1 | 344.50 | +3.05 | +0.89% |
| PIVOT | 341.75 | 0.30 | 0.09% |
| CURRENT | 341.45 | — | — |
| S1 | 338.70 | -2.75 | -0.81% |
| S2 | 335.95 | -5.50 | -1.61% |
| S3 | 332.90 | -8.55 | -2.50% |
| S4 | 327.10 | -14.35 | -4.20% |
FDC is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹339.4–₹344
Trading Below opening range, showing Bearishness
FDC financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for FDC — consolidated or standalone — with margins, YoY growth and key ratios inline.
FDC reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹5,568.1 Cr. and reported EPS of ₹8.11.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 2,108 | 2,171 ▲ 3.0% |
| Sales Growth YoY %Derived | 8.50% | 2.98% |
| Other Income | 91 | 114 ▲ 25.2% |
| Total Income | 2,199 | 2,284 ▲ 3.9% |
| 736 | 711 ▼ 3.4% | |
| Gross ProfitDerived | 1,372 | 1,460 ▲ 6.4% |
| Gross Margin %Derived | 65.07% | 67.25% |
| 1,047 | 1,114 ▲ 6.4% | |
| EBITDA (Operating Profit)Derived | 325 | 346 ▲ 6.6% |
| OPM %Derived | 15.41% | 15.94% |
| 58 | 43 ▼ 25.4% | |
| Profit Before Tax (PBT) | 357 | 375 ▲ 4.9% |
| 90 | 93 ▲ 3.0% | |
| Effective Tax %Derived | 25.31% | 24.87% |
| Total Profit for Period | 267 | 281 ▲ 5.5% |
| Less: Non-controlling Interests | — | — |
| Net Profit (Owner's PAT)Derived | 267 | 281 ▲ 5.5% |
| Net Profit Margin %Derived | 12.66% | 12.96% |
| PAT Growth YoY %Derived | -12.59% | 5.49% |
| Earnings Per Share (EPS ₹) | 16.39 | 17.29 ▲ 5.5% |
| Diluted Shares Outstanding (Cr) | 16 | 16 ▲ 0.0% |
| Share of Profit from Associates/JVs | — | — |
| Other Comprehensive Income (Net of Tax) | -1 | 4 ▲ 372.9% |
| Total Expenses (incl. D&A & Interest) | 1,842 | 1,910 ▲ 3.7% |
| Material Cost % of RevenueDerived | 27.57% | 26.55% |
| Employee Cost % of RevenueDerived | 22.88% | 22.23% |
| Other Cost % of RevenueDerived | 26.79% | 29.08% |
| Interest Coverage (x)Derived | 60.11x | 57.54x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,083 | 1,344 ▲ 24.1% | 1,333 ▼ 0.8% | 1,528 ▲ 14.6% | 1,784 ▲ 16.7% | 1,943 ▲ 8.9% | 2,108 ▲ 8.5% | 2,171 ▲ 3.0% | |
| Sales Growth YoY %Derived | — | 24.11% | -0.82% | 14.61% | 16.74% | 8.92% | 8.50% | 2.98% | |
| Other Income | 51 | 69 ▲ 35.2% | 97 ▲ 40.8% | 76 ▼ 21.6% | 50 ▼ 34.5% | 102 ▲ 103.9% | 91 ▼ 10.8% | 114 ▲ 25.2% | |
| Total Income | 1,134 | 1,413 ▲ 24.6% | 1,430 ▲ 1.2% | 1,604 ▲ 12.2% | 1,834 ▲ 14.3% | 2,045 ▲ 11.5% | 2,199 ▲ 7.5% | 2,284 ▲ 3.9% | |
352 | 426 ▲ 20.9% | 414 ▼ 2.7% | 530 ▲ 28.1% | 656 ▲ 23.7% | 656 ▲ 0.1% | 736 ▲ 12.2% | 711 ▼ 3.4% | ||
| Gross ProfitDerived | 731 | 918 ▲ 25.6% | 919 ▲ 0.1% | 998 ▲ 8.5% | 1,128 ▲ 13.1% | 1,287 ▲ 14.1% | 1,372 ▲ 6.6% | 1,460 ▲ 6.4% | |
| Gross Margin %Derived | 67.49% | 68.33% | 68.94% | 65.30% | 63.24% | 66.23% | 65.07% | 67.25% | |
504 | 626 ▲ 24.0% | 585 ▼ 6.5% | 744 ▲ 27.2% | 877 ▲ 17.9% | 948 ▲ 8.1% | 1,047 ▲ 10.4% | 1,114 ▲ 6.4% | ||
| EBITDA (Operating Profit)Derived | 227 | 293 ▲ 29.2% | 334 ▲ 14.0% | 254 ▼ 24.1% | 251 ▼ 1.1% | 339 ▲ 34.9% | 325 ▼ 4.1% | 346 ▲ 6.6% | |
| OPM %Derived | 20.93% | 21.79% | 25.06% | 16.60% | 14.07% | 17.42% | 15.41% | 15.94% | |
36 | 41 ▲ 13.3% | 39 ▼ 4.3% | 40 ▲ 3.3% | 43 ▲ 6.5% | 44 ▲ 2.1% | 58 ▲ 32.5% | 43 ▼ 25.4% | ||
| Profit Before Tax (PBT) | 241 | 321 ▲ 33.4% | 388 ▲ 20.8% | 289 ▼ 25.4% | 258 ▼ 10.9% | 396 ▲ 53.7% | 357 ▼ 9.8% | 375 ▲ 4.9% | |
67 | 80 ▲ 19.3% | 87 ▲ 8.1% | 73 ▼ 15.4% | 64 ▼ 12.6% | 91 ▲ 42.5% | 90 ▼ 0.8% | 93 ▲ 3.0% | ||
| Effective Tax %Derived | 27.89% | 24.95% | 22.32% | 25.30% | 24.82% | 23.01% | 25.31% | 24.87% | |
| Total Profit for Period | 174 | 240 ▲ 38.3% | 301 ▲ 25.6% | 216 ▼ 28.2% | 194 ▼ 10.3% | 305 ▲ 57.4% | 267 ▼ 12.5% | 281 ▲ 5.5% | |
| Less: Non-controlling Interests | — | — | -0 | -0 ▲ 88.4% | -0 ▼ 1138.5% | -0 ▲ 21.4% | — ▲ 100.0% | — | |
| Net Profit (Owner's PAT)Derived | 174 | 240 ▲ 38.3% | 301 ▲ 25.6% | 216 ▼ 28.3% | 194 ▼ 10.2% | 305 ▲ 57.3% | 267 ▼ 12.6% | 281 ▲ 5.5% | |
| Net Profit Margin %Derived | 16.02% | 17.85% | 22.60% | 14.15% | 10.88% | 15.71% | 12.66% | 12.96% | |
| PAT Growth YoY %Derived | — | 38.25% | 25.62% | -28.26% | -10.24% | 57.30% | -12.59% | 5.49% | |
| Earnings Per Share (EPS ₹) | 9.95 | 14.03 ▲ 41.0% | 17.85 ▲ 27.2% | 12.81 ▼ 28.2% | 11.70 ▼ 8.7% | 18.75 ▲ 60.3% | 16.39 ▼ 12.6% | 17.29 ▲ 5.5% | |
| Diluted Shares Outstanding (Cr) | 17 | 17 ▼ 2.0% | 17 ▼ 1.3% | 17 ▲ 0.0% | 17 ▼ 1.7% | 16 ▼ 1.9% | 16 ▲ 0.0% | 16 ▲ 0.0% | |
| Share of Profit from Associates/JVs | — | -1 | 0 ▲ 101.9% | — ▼ 100.0% | — | — | — | — | |
| Other Comprehensive Income (Net of Tax) | 2 | -3 ▼ 283.5% | 5 ▲ 246.3% | 7 ▲ 47.6% | 1 ▼ 87.9% | 2 ▲ 122.3% | -1 ▼ 178.3% | 4 ▲ 372.9% | |
| Total Expenses (incl. D&A & Interest) | 893 | 1,092 ▲ 22.2% | 1,043 ▼ 4.5% | 1,315 ▲ 26.1% | 1,576 ▲ 19.9% | 1,648 ▲ 4.6% | 1,842 ▲ 11.7% | 1,910 ▲ 3.7% | |
| Material Cost % of RevenueDerived | 25.32% | 25.17% | 26.00% | 29.73% | 32.85% | 30.09% | 27.57% | 26.55% | |
| Employee Cost % of RevenueDerived | 20.00% | 20.64% | 22.22% | 22.47% | 21.91% | 21.28% | 22.88% | 22.23% | |
| Other Cost % of RevenueDerived | 26.56% | 25.89% | 21.66% | 26.22% | 27.25% | 27.53% | 26.79% | 29.08% | |
| Interest Coverage (x)Derived | 136.34x | 74.79x | 86.26x | 70.04x | 51.88x | 74.03x | 60.11x | 57.54x |
FDC segment analysis : revenue and profit mix.
Disclosed business segments at FDC with their share of revenue and profit, switchable between consolidated and standalone reporting.
FDC discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for FDC.
Our AI distills the core fundamental drivers supporting FDC, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
FDC's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Strong promoter holding of 69.66% ensures stable governance and long-term commitment.
Ultra-low debt-to-equity ratio of 0.0000 minimizes financial risk and leverage concerns.
Operating margin of 18.03% demonstrates efficient cost management and operational profitability.
Cash flow per share of ₹12.31 indicates robust liquidity and shareholder value generation.
Diversified brand portfolio including Zifi, Zefu, Zocon, Electral provides competitive moat.
Key Risks.
Latest quarterly EPS grew 167.4% YoY, but quarterly sales growth only 1.92% signals disconnect.
High P/E ratio of 24.90 suggests potential overvaluation relative to earnings multiples.
FII holdings eased from 3.99% to 2.43%, signaling reduced foreign investor confidence.
Market cap of ₹5,568.10 Cr is smallest among pharma peers, limiting scale and bargaining power.
ROE of 11.47% and ROCE of 11.69% lag industry benchmarks for pharmaceutical companies.
Flip Conditions.
Valuation risk. a P/E above 25 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.73%.
FDC peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — FDC is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
FDC chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for FDC — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
FDC delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for FDC over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in FDC stood at 68.8% of traded volume, against a 20-day average of 57.9%.
FDC announcements: results, concalls, ratings, M&A.
Filings FDC sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
FDC files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 79 documents below.
Copy of Newspaper Publication
FDC Limited has informed the Exchange about Copy of Newspaper Publication
Record Date
FDC Limited has informed the Exchange that Record date for the purpose of Meeting is 16-Sep-2026.
Shareholders meeting
FDC Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026
Copy of Newspaper Publication
FDC Limited has informed the Exchange about the newspaper publication in respect of the 86th AGM.
General Updates
FDC Limited has informed the Exchange about Interim Stay received from The Honourable High Court of Delhi, New Delhi
FDC dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue FDC has declared, sequenced by announce and record date.
FDC corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About FDC: business, sector, key facts.
What FDC does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
FDC operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: FDC, BSE: 531599.
FDC Limited is a pharmaceutical company with a long history, established in 1936 and headquartered in Mumbai, India. Its core business revolves around the manufacture and marketing of a wide range of pharmaceutical products both domestically within India and internationally. The company's product portfolio is extensive and caters to various therapeutic areas, demonstrating a diverse approach to market segments.
FDC's product offerings span a considerable spectrum of therapeutic categories. These include anti-infectives to combat infections, gastrointestinal medications for digestive health, and ophthalmic products for eye care. Furthermore, they produce vitamins, minerals, and dietary supplements targeting overall health and wellness. Their product line also extends to treatments for cardiac conditions, diabetes, respiratory illnesses, gynecological issues, dermatological problems, and pain management (analgesics). Beyond traditional pharmaceuticals, they also manufacture and market a range of nutraceuticals, including anti-oxidants, balanced energy and protein drinks.
The company leverages a portfolio of established brand names to market its products. These brands, such as Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal, represent a significant investment in brand recognition and consumer trust. This multi-brand strategy likely helps FDC target diverse market segments and consumer needs within the pharmaceutical and nutraceutical sectors.
In addition to finished pharmaceutical products, FDC also manufactures active pharmaceutical ingredients (APIs). This vertical integration provides the company with greater control over its supply chain and potentially allows for cost efficiencies and enhanced product quality. By controlling the production of core components, FDC likely mitigates risks associated with reliance on external API suppliers.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AAREY DRUGS & PHARM (AAREYDRUGS) Share PricePeer
- AARTI DRUGS (AARTIDRUGS) Share PricePeer
- AARTI PHARMALABS (AARTIPHARM) Share PricePeer
- AJANTA PHARMA (AJANTPHARM) Share PricePeer
- AKUMS DRUGS AND PHARMA L (AKUMS) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about FDC (FDC).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of FDC (FDC)?
The current share price of FDC (FDC) is ₹341.45. Today, the stock has declined by ₹3.90 (1.13%), trading in a range of ₹339.00 to ₹344.80. The stock opened at ₹344.00 with a trading volume of 1,36,483 shares.
02Is FDC stock a good investment for long-term?
FDC can be considered for long-term investment based on several factors. The company has a market capitalization of ₹5,568.1 Cr., P/E ratio of 19.03, ROE of 11.47%, and ROCE of 11.8%. The dividend yield stands at 1.46%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of FDC stock?
The 52-week high price of FDC (FDC) is ₹527.80, while the 52-week low is ₹312.95. Currently trading at ₹341.45, the stock is 9.11% above its 52-week low and 35.31% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy FDC stock at the current price?
Whether to buy FDC stock at ₹341.45 depends on multiple factors. The stock is currently trading with a P/E ratio of 19.03 and P/B ratio of 2.24. Today's performance shows a loss of 1.13%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of FDC and when is the next dividend?
FDC offers a dividend yield of 1.46%, which means for every ₹100 invested at the current price of ₹341.45, you can expect to receive approximately ₹1.46 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of FDC?
FDC's key financial metrics include: P/E Ratio: 19.03, P/B Ratio: 2.24, ROE: 11.47%, ROCE: 11.8%, Dividend Yield: 1.46%, EPS: ₹8.11, Book Value: ₹152.64, and Debt-to-Equity: 0. The company's market cap stands at ₹5,568.1 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is FDC stock performing today in the market?
FDC stock opened at ₹344.00 and is currently trading at ₹341.45, showing a decline of ₹3.90 (1.13%). The intraday high is ₹344.80 and low is ₹339.00. The trading volume stands at 1,36,483 shares, indicating moderate market participation today.
08What is the P/E ratio of FDC and what does it indicate?
FDC has a Price-to-Earnings (P/E) ratio of 19.03, which means investors are willing to pay 19.03 for every ₹1 of earnings. With an EPS of ₹8.11, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about FDC (FDC) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.